Organoid drug screening report for a non-small cell lung cancer patient with EGFR gene mutation negativity: A case report and review of the literature

Patients with non-small cell lung cancer (NSCLC) who carry epidermal growth factor receptor (EGFR) mutations can benefit significantly from EGFR tyrosine kinase inhibitors (EGFR TKIs). However, it is unclear whether patients without EGFR mutations cannot benefit from these drugs. Patient-derived tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yuetian, Cui, Hongshang, Song, Yongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978590/
https://www.ncbi.nlm.nih.gov/pubmed/36874139
http://dx.doi.org/10.3389/fonc.2023.1109274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978590/
https://www.ncbi.nlm.nih.gov/pubmed/36874139
http://dx.doi.org/10.3389/fonc.2023.1109274

Ejemplares similares